To the Editor We read with interest the study of surgeon attitudes toward the omission of axillary lymph node dissection (ALND) in early breast cancer.1 A previous survey of 849 members of the American Society of Breast Surgeons suggested that “respondents have embraced [the ACOSOG] Z0011 [trial] and omit ALND in patients with 1 or 2 positive nodes.”2 In contrast, we now learn that only higher-volume breast cancer surgeons with multidisciplinary interactions are less likely to propose ALND for patients with limited disease in the sentinel node, whereas low-volume surgeons should be targeted for remedial education.1
Goyal A, Mann B, Thompson AM. Undissected Axilla and Axillary Radiotherapy. JAMA Oncol. 2019;5(5):741–742. doi:10.1001/jamaoncol.2019.0031
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.